Q1 2023 · —
Revenue—
Net Income-$7.41M-$7.41M no prior Q1 2022 on file
EPS, diluted—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q1 2022 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bicara Therapeutics Inc. · CIK 2023658 · Engraved from SEC EDGAR